| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 49.7109 | 48 |
| GSM780708 | Untreated after 4 days (C2_1) | 49.0529 | 45 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.9974 | 27 |
| GSM780719 | Untreated after 4 days (C1_2) | 40.4552 | 8 |
| GSM780720 | Untreated after 4 days (C2_2) | 55.1637 | 60 |
| GSM780721 | Untreated after 4 days (C3_2) | 42.2845 | 14 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.4558 | 50 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 44.4738 | 24 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.613 | 16 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.3266 | 38 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 51.0048 | 51 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 60.5287 | 65 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 45.2218 | 28 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.9356 | 36 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 53.3992 | 57 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.9402 | 41 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 40.4792 | 8 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.0052 | 45 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.0405 | 27 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 56.3912 | 61 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 45.6119 | 30 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.5218 | 25 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 47.5308 | 39 |